Clinical Trial

Evaluation of Pain Treatment After Total Knee Arthroplasty

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-14
Trial Details
NCT Number NCT07538570
Lead Sponsor Vertex Pharmaceuticals Incorporated
Conditions Pain
Enrollment 60 participants
Start Date 2026-04-24
Primary Completion 2027-01-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-13